IPO Update: Average Return Turns Negative For Newly Public Biopharma Firms

Number Of IPOs Tops 2020 Total With A Quarter Left In 2021

 
• By Mandy Jackson
  
IPO icon over $100 bill
Biopharma IPOs occurred in the US in record numbers but delivered mostly negative returns • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Business